Merger Monday

Written by Rob Goldman   

Last week, we strongly recommended buying AMR Corp (NASDAQ – AAMRQ - $2.54), ahead of an expected merger announcement with US Airways (LCC). We are proud to say that the stock flew 73% higher in a week.

Now there is a story that has surfaced regarding a merger in the office supply industry. How should you play it? Read on. Plus, a primer as to why the stock market could start to take hit---thanks to government ineptitude.

Finally, our daily blogs are consistently big winners. Check out the chart which shows our top 5 picks in 2013 are up an average of 28% in 30 days or less.


February 18, 2013
Volume 3, Number 33

The Goldman Guide

Your Tax Dollars At Work

Nothing seems to be able to curtail this market upswing, or so it seems.  What may end up stopping it dead in its tracks may be the U.S. government. By now, I am sure many of you are aware of the “sequestration.” It is a hot button issue here in Maryland, which is     heavily reliant on government spending.

Here’s the basic story. Remember the failed 2011 budget situation? In August 2011, with the nation's debt-limit deadline approaching, and with the threat of credit downgrades and government shutdowns        looming over partisan negotiations in Washington, the Obama Administration and House Republicans agreed on a Budget Control Act. This Act created a congressional budget "supercommittee" that was charged with proposing a deadline-based package of spending cuts and/or tax hikes to lower the deficit.

If the committee couldn't recommend a package by late 2011, and if Congress couldn't pass it in January 2012, $1.2 trillion in automatic cuts would be triggered. Deadline extensions were enacted and passed     without any agreement. As a result, unless an agreement is reached soon, these cuts will become effective on March 1.

The spending cuts, which will to a degree be overseen by the Office of Management and Budget, include mandatory and discretionary spending cuts, including up to 10% reductions in some areas which could lead to furloughs.

The timing is awful as it could negatively impact economic growth, which is already anemic and hurting from rising gas prices.  The parties can get their act together and avoid the tenuous situation. It may result in additional deadlines, which could give us some breathing room. Regardless, this uncertainty could prompt the market begin to decline.

Merger Monday

In last week’s edition of The Goldman Guide, we profiled the pending deal between AMR Corp (NASDAQ—AAMRQ—$2.54) and US Airways (NYSE—LCC) and strongly suggested playing AMR for a quick pop, ahead of definitive news of the deal.

While we had a strong sense that the stock would do well, it well, flew much higher, jumping 73% by week’s end. If you did buy the stock, we would certainly recommend taking profits.

We have frequently mentioned that there are usually swift capital gain opportunities when these deals are rumored or even announced. With that in mind, many investors may have caught a story on Monday that the long-rumored combination of Office Depot (NYSE—ODP—$4.59) and OfficeMax (NYSE—OMX—$10.75) may actually come to fruition this week.

There may in fact be a quick gain lurking in one of these stocks, but we caution that it will not be anything like the airline combination announced last week. This deal is a merger whose details are still being ironed out and who both have activist investor groups that could throw a wrench into a deal, in the worst case scenario, or maybe even make sure it happens, depending upon terms, in the best case.

The better play of the two is probably ODP, but since we do not know who will be the successor firm or any real information it is impossible to quantify and classify this transaction.

We think OMX could be the successor firm due to its greater profitability metrics, despite the fact that ODP is larger in terms of revenue and store count. What is clear is that it will be a stock swap which is par for the course, given the situation.  ODP could provide investors with 10-20% returns, if terms are favorable. If a deal does not occur, which right now seems unlikely, we would definitely avoid both stocks as a deal seems necessary for survival.

Mid-1Q Scorecard

(from Friday’s February 15, 2013 Market Monitor’s blog)

I bet you are asking yourself, now that we are midway through the first quarter of 2013, how are those daily blog picks working out?  Well, maybe you haven’t, but we have. Without further ado here is a snapshot of our mid-1Q13 blog stock pick performance. As you likely recall, the daily blog objective is provide you daily insight into stocks that we believe could make a big move in the short term, as in a matter of weeks.  Sometimes we get it right and other times we do not.  The most important thing is for the performance of right calls to be far greater than the wrong calls. By that measure, it looks like “mission accomplished.”

As of the close of the market on February 14th, we have highlighted a grand total of 21 stocks, year-to-date, under our Market Monitor blog posts. As you can see by the table below, our top 5 picks are up an average of 28% in 30 days or less, while our bottom 5 performers are down an average of 8.2% for the same period.

The Big Winner

JFBI is just on fire!  It has surpassed our $5 level and then some.  As we mentioned in the original blog post last week, there really is no news or backing fundamentals, but the stock continues to climb.  The charts remain bullish in the short term but selling a portion of the position is a prudent move.

Until next week….

Analyst: Robert Goldman

Rob Goldman founded Goldman Small Cap Research (GSCR) in 2009. Rob has over 20 years of investment and research experience as a senior research analyst and as a portfolio and mutual fund manager. During his tenure as a sell-side analyst, he was a senior member of Piper Jaffray's Technology team. Prior to joining Piper, Rob led Josephthal & Co.'s Emerging Growth Research Group. Rob has also served as Chief Investment Officer of two boutique investment management firms, where he managed Small Cap Growth and Balanced portfolios and The Blue and White Fund.  As an investment manager, Rob's model portfolio was once ranked the 4th best small cap growth performer in the U.S. by Money Manager Review. In addition to his work at GSCR, Rob is the editor of Penny Stock Junction (www.pennystockjunction.com.)

Analyst Certification

I, Robert Goldman, hereby certify that the view expressed in this newsletter accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this research publication.

Disclaimer

This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap and mid cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.

It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This report or newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This report or newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority.

ALL INFORMATION IN THIS REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

For more information, visit our Disclaimer: www.goldmanresearch.com.